For the second time in three years, the Best of State Program's independent judges have recognized American Biotech Labs(R) as Utah's top company in the Medical Innovation category
SALT LAKE CITY, UT, June 4 /PRNewswire/ - American Biotech Labs, LLC (ABL), developer of a new class of products based on the company's patented nano-catalytic SilverSol Technology(R), today announced that the company has won the 2009 Utah Best of State award in the category of Medical Innovation. It is the company's second Best of State award in the past three years.
"We are honored that the Best of State judges have chosen to honor ABL with a 2009 Best of State award in the Medical Innovation category," said Dr. William Moeller, a managing director at American Biotech Labs. "This recognition highlights the reality that we are in the midst of a period of tremendous growth, as an increasing number of people throughout the world are beginning to recognize the benefits of ABL's uniquely effective patented silver products."
ABL received its Best of State award May 30 at the 2009 Best of State Awards Gala, a formal dinner event in the Salt Palace Convention Center Ballroom in Salt Lake City. The Best of State program, now in its seventh year, is a multi-faceted recognition program created by award-winning writer, producer and director Mark Layton and 20-year production and management executive Dana Layton to highlight excellence in business, government, education, philanthropy and the arts in Utah.
Winners for the annual Best of State event are chosen for their excellence in a wide variety of endeavors. Candidates are judged based on three criteria: achievement within their field of endeavor (50 percent); innovation or creativity in approach, techniques, methods or processes (30 percent); and contribution to improving the quality of life in Utah (20 percent). Best of State nominees are evaluated by a panel of more than 100 independent judges.
ABL products have received multiple U.S. and international patents and government approvals, including EPA and FDA approval. Most recently, in April 2009, the U.S. Food and Drug Administration (FDA) granted ABL's ASAP Wound Dressing Gel with 510(k) medical device approval "for the topical management of minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin irritations." The product utilizes ABL's innovative SilverSol Technology, which has garnered multiple patents in the U.S. and countries throughout the world, including a broad-spectrum use patent for combating many of the world's most destructive pathogens, including malaria, tuberculosis, MRSA and HIV.
ABL has performed extensive anti-microbial studies against bacteria, yeast, fungus and other pathogens. Information about some of these studies is available at the research section of the ABL Website, www.americanbiotechlabs.com/researchprotected/researchmenu.html.
About American Biotech Labs
American Biotech Labs (ABL; www.americanbiotechlabs.com), founded in 1998, utilizes patented processes and SilverSol Technology(R) to create singularly powerful and effective nano-catalytic silver products. In extensive testing performed by a variety of respected laboratories and researchers, ABL's silver hydrosol has consistently demonstrated the ability, without any known toxic side effects, to destroy a wide range of bacteria, viruses, yeast, and molds. ABL products have been approved by the Environmental Protection Agency (EPA) as a disinfectant for dental water lines, and as a surface disinfectant for bacteria, yeast and mold in hospital, residential, commercial and industrial settings; and by the U.S. Food and Drug Administration (FDA) for wound management. The company's products have been the subject of multiple peer-reviewed articles in professional journals, and are sold worldwide at health food stores and by medical professionals under the Silver Biotics(R) and ASAP Solution(R) brands, and through a variety of private labels.
|SOURCE American Biotech Labs, LLC|
Copyright©2009 PR Newswire.
All rights reserved